As of June 2026, FTI's trailing twelve months (TTM) EPS stands at $2.66, according to the latest financial reports. In 2025, the company recorded an earnings per share (EPS) of $2.34, which represents an increase compared to its EPS of $1.96 in 2024. FTI reported an EPS of $0.65 for the quarterly report ending on Mar 31, 2026.
For 2025, TechnipFMC's EPS was $2.34, an increase of 19.4% from $1.96 in 2024. For the quarter ending Mar 31, 2026, the EPS was $0.65, showing a 91.2% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is $2.66. In 2024, the annual EPS was $1.96, showing an increase of 1,407.7% from 2023.
Over the last 12 months, TechnipFMC has registered an EPS growth of 91.2% (YoY, quarterly). A 10-year view shows that FTI has seen an average EPS growth of 33.5% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| SLB Schlumberger Limited | 20.78 | -24.2% | -0.7% | N/A |
| FTI TechnipFMC plc | 24.86 | 19.4% | N/A | N/A |
| INVX Innovex International Inc. | 33.75 | -57.1% | -16.4% | N/A |
| GE General Electric Co | 43.58 | 35.8% | 447.4% | 12.1% |
| NOV National Oilwell Varco Inc | 75 | -75.9% | -0.8% | N/A |
| OIS Oil States International Inc | N/A | -933.3% | N/A | N/A |
| FET Forum Energy Technologies Inc | N/A | 92.6% | N/A | N/A |
| BOLT Bolt Biotherapeutics Inc | N/A | 46% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.